Recover Investment Losses: Class Action Initiated Against Beta Bionics, Inc. (BBNX)

Levi & Korsinsky announced a securities class action filed against Beta Bionics (BBNX) covering investors who purchased securities between July 30, 2025 and February 24, 2026. The complaint alleges defendants downplayed an FDA Form 483 that identified over 18,000 complaints out of fewer than 30,000 total iLet users, including life-threatening hypoglycemic events allegedly not investigated or reported to the FDA.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.